Reactor Production of Other Medical Isotopes

Session Organizers:
Natesan Ramamoorthy, Homi Bhabha National Institute, India

Cathy Cutler, University of Missouri, USA

Radioisotopes produced in reactors represent the vast majority of the radioisotopes used owing to their large volume for irradiation, simultaneous irradiation of several samples, economy of production and ability to produce a wide variety of radioisotopes. This session will cover the current state of isotope production including challenges and areas of improvement including novel radiochemical processing methods, addressing novel indirect methods of production, new radioisotopes, new generator and technology including novel chemistries to meet changing market demands.


Novel Radionuclide Production at Polatom
Renata Mikolajczak, NCBJ Radioisotope Centre POLATOM, Poland

The necessity of research reactors for radioisotope production
Bernard Ponsard, SCK.CEN – BR2 Reactor, Belgium

The state of isotope production in China and the CARR reactor
Zhifu Luo, Department of Isotopes, China Institute of Atomic Energy, China

Production of Radioisotopes at the Jules Horowitz Reactor
Jean-Pierre Coulon, Atomic Energy and Alternatives Energies Commission, CEA, DEN, Cadarache, France

Novel production of radionuclides at MURR
Cathy S. Cutler, Radiopharmaceutical Sciences Institute, Nuclear Engineering Department, MURR, United States